Aller au contenu principal
Accès ouvert déclaré 2026 article

The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients

1Citations signalées, ce qui n’est pas une note de qualité
63Institutions déclarées
18Pays d’affiliation déclarés

Rattachement africain : dk, us, de, no, jp, cy, gr, es, fr, kr, ch, cn, br, ca, hu, in, it, se. Niveau de preuve : code pays fourni par la source.

Le résumé fourni par la source

PURPOSE: The Ki-67 proliferation index (Ki-67 PI) has been associated with meningioma recurrence, yet its clinical utility remains debated. Whether Ki-67 PI provides prognostic information across subgroups defined by both WHO grade and extent of resection remains to be investigated. METHODS: We analyzed 5,050 patients with intracranial meningiomas from the international PERNS cohort (42 centers, diagnosed between 1989-2019) who underwent surgical resection without postoperative radiotherapy. Ki-67 PI prognostic accuracy was assessed up to 10 years postoperatively by using ROC analyses and estimating its association with the risk of recurrence. RESULTS: Results demonstrated that the prognostic value of Ki-67 PI differed by subgroups defined by WHO grade and Simpson grade. For patients with the same Simpson grade (1-3), the predictive accuracy of Ki-67 PI for 10-year recurrence risk was stronger in WHO-2 than in WHO-1. Within WHO-1 and WHO-2 meningiomas, the predictive accuracy of Ki-67 PI increased with higher Simpson grade (1-3). However, no predictive value was observed in Simpson grade 4 resections regardless of WHO grade. CONCLUSION: These findings highlight that Ki-67 PI should be interpreted in the context of both WHO grade and extent of resection, and, if done so, may offer potential value to refine individualized surveillance strategies in meningioma patients with gross total resection in the initial 10-year postoperative timeframe. Findings cannot be extrapolated beyond 10 years, which may be particularly relevant for WHO-1 tumors with low Ki-67 PI and Simpson grade 1 resection.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Le contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
The Ki-67 proliferation index and recurrence risk of intracranial meningioma: a multicenter, retrospective cohort study of 5,050 patients
Date Crossref
06/04/2026
Éditeur
Springer Science and Business Media LLC
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.

Les institutions déclarées

Copenhagen University HospitalMassachusetts General HospitalCenter for Neuro-OncologyCenter for Cancer ResearchUniversity Hospital Carl Gustav CarusTechnische Universität DresdenNorwegian University of Science and TechnologySt Olav's University HospitalHarvard UniversityUniversity of California, San FranciscoNeurological SurgeryNorthwestern UniversityUniversity of MünsterClemenshospital MünsterSocial Insurance Saitama Chuo HospitalSaitama Medical UniversityUniversity of Tokyo HospitalUniversity Hospital RegensburgTokyo Women's Medical University Adachi Medical CenterEuropean University CyprusAthens Medical CenterSmilow Cancer HospitalLeitat Technological CenterUniversité Paris CitéHôpital BeaujonAssistance Publique – Hôpitaux de ParisLoyola University Medical CenterUniversity Hospital LeipzigUniversity of Occupational and Environmental Health JapanSamsung (South Korea)Sungkyunkwan UniversitySeoul National UniversitySeoul National University HospitalUniversity of Illinois ChicagoUniversity of Illinois Hospital & Health Sciences SystemUniversity of Wisconsin–MadisonUniversity of UtahYonsei UniversityUniversity Hospital of BaselFirst Affiliated Hospital of Zhengzhou UniversityUniversidade Federal de São PauloHackensack Meridian HealthSylvester Comprehensive Cancer CenterAllegheny General HospitalMcGill University Health CentreUniversity of DebrecenTohoku Medical and Pharmaceutical UniversityMobile InfirmaryHuntsman Cancer InstituteTata Memorial HospitalAdvanced Centre for Treatment, Research and Education in CancerBaylor College of MedicineNeurological Research InstituteTexas Children's HospitalGangnam Severance HospitalUniversity of Naples Federico IIUniversity of VeronaFondazione IRCCS Istituto Neurologico Carlo BestaInstituto de Investigación Biomédica de SalamancaKarolinska InstitutetUniversity of CopenhagenRigshospitaletStatens Serum Institut

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Les sujets associés

Meningioma and schwannoma managementBrain Metastases and TreatmentGlioma Diagnosis and Treatment

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.